Form D · Biotechnology
New Day Diagnostics LLC
Knoxville, TN · CIK 0001989944
Offering snapshot reported Aug 15, 2023 · SEC filing
- Reported sold
- Yet to sell Offering amount: $15M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489787
Source: Form D, filed Aug 15, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Allyn | Director |
| Autumn Anfang | Director |
| Chris Chandler | Director |
| Scott Gucciardi | Director |
| William Kouns | Director |
| Sam Libby | Executive |
| Eric Mayer | Director, Executive |
| Navroze Mehta | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6701 Baum Drive, Suite 110
Knoxville, TN, 37919
Knoxville, TN, 37919